| Literature DB >> 27199752 |
Irene Lorrai1, Valentina Piga1, Mauro A M Carai2, Antonella Riva3, Paolo Morazzoni3, Gian Luigi Gessa1, Giancarlo Colombo1, Paola Maccioni1.
Abstract
Previous evidence has suggested that treatment with a standardized dry extract of Phaseolus vulgaris reduced intake and operant self-administration of highly palatable foods and fluids in rats and mice. The present study was designed to assess whether such extract was also effective in reducing seeking behavior for a highly hedonic chocolate-flavored beverage, using a "reinstatement" procedure adopted from the drug addiction research field and modeling relapse behavior. Rats were initially trained to lever-respond for the chocolate-flavored beverage under the Fixed Ratio (FR) 10 schedule of reinforcement. Subsequently, rats were exposed to an extinction responding phase, during which lever-responding - being unreinforced - diminished progressively up to extinction. Lever-responding was then powerfully reinstated by the non-contingent presentation of a complex of gustatory, olfactory, auditory, and visual stimuli previously associated to the availability of the chocolate-flavored beverage. Acute, intragastric administration of P. vulgaris dry extract (100 and 500 mg/kg) reduced lever-responding by 40-45%, in comparison to vehicle condition. These results indicate the ability of P. vulgaris dry extract to reduce seeking behavior for a highly palatable nourishment in an experimental model of relapse into disordered eating of palatable foods. The unavailability of the chocolate-flavored beverage in the reinstatement session tends to exclude that the observed effect of the P. vulgaris dry extract was secondary to any inhibition of carbohydrate metabolism; conversely, it is the likely consequence on a central action on the rewarding and hedonic properties of food.Entities:
Keywords: Phaseolus vulgaris dry extract (Beanblock®); chocolate-flavored beverage; rats; reinstatement of seeking behavior; relapse-like behavior
Year: 2016 PMID: 27199752 PMCID: PMC4845070 DOI: 10.3389/fphar.2016.00109
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810